FDA More Problematic Than Obamacare, Says Acorda CEO - TheStreet

FDA More Problematic Than Obamacare, Says Acorda CEO

Ron Cohen, CEO of Acorda Therapeutics, says his company's pipeline is full and he is less worried about Obamacare than the FDA.
Author:
Publish date:

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.